Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1997 Oct;10(4):637–649. doi: 10.1128/cmr.10.4.637

Progress towards development of a vaccine for amebiasis.

S L Stanley Jr 1
PMCID: PMC172938  PMID: 9336666

Abstract

The application of molecular biologic techniques over the past decade has seen a tremendous growth in our knowledge of the biology of Entamoeba histolytica, the causative agent of amebic dysentery and amebic liver abscess. This approach has also led to the identification and structural characterization of three amebic antigens, the serine-rich Entamoeba histolytica protein (SREHP), the 170-kDa subunit of the Gal/GalNAc binding lectin, and the 29-kDa cysteine-rich protein, which all show promise as recombinant antigen-based vaccines to prevent amebiasis. In recent studies, an immunogenic dodecapeptide derived from the SREHP molecule has been genetically fused to the B subunit of cholera toxin, to create a recombinant protein capable of inducing both antiamebic and anti-cholera toxin antibodies when administered by the oral route. Continued progress in this area will bring us closer to the goal of a cost-effective oral combination "enteric pathogen" vaccine, capable of inducing protective mucosal immune responses to several clinically important enteric diseases, including amebiasis.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abou-el-Magd I., Soong C. J., el-Hawey A. M., Ravdin J. I. Humoral and mucosal IgA antibody response to a recombinant 52-kDa cysteine-rich portion of the Entamoeba histolytica galactose-inhibitable lectin correlates with detection of native 170-kDa lectin antigen in serum of patients with amebic colitis. J Infect Dis. 1996 Jul;174(1):157–162. doi: 10.1093/infdis/174.1.157. [DOI] [PubMed] [Google Scholar]
  2. Andrä J., Berninghausen O., Wülfken J., Leippe M. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity. FEBS Lett. 1996 Apr 29;385(1-2):96–100. doi: 10.1016/0014-5793(96)00359-6. [DOI] [PubMed] [Google Scholar]
  3. Andrä J., Leippe M. Pore-forming peptide of Entamoeba histolytica. Significance of positively charged amino acid residues for its mode of action. FEBS Lett. 1994 Oct 31;354(1):97–102. doi: 10.1016/0014-5793(94)01103-6. [DOI] [PubMed] [Google Scholar]
  4. Bessen D., Fischetti V. A. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun. 1988 Oct;56(10):2666–2672. doi: 10.1128/iai.56.10.2666-2672.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Betley M. J., Miller V. L., Mekalanos J. J. Genetics of bacterial enterotoxins. Annu Rev Microbiol. 1986;40:577–605. doi: 10.1146/annurev.mi.40.100186.003045. [DOI] [PubMed] [Google Scholar]
  6. Beving D. E., Soong C. J., Ravdin J. I. Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity. Infect Immun. 1996 Apr;64(4):1473–1476. doi: 10.1128/iai.64.4.1473-1476.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Braga L. L., Ninomiya H., McCoy J. J., Eacker S., Wiedmer T., Pham C., Wood S., Sims P. J., Petri W. A., Jr Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest. 1992 Sep;90(3):1131–1137. doi: 10.1172/JCI115931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bruchhaus I., Tannich E. Analysis of the genomic sequence encoding the 29-kDa cysteine-rich protein of Entamoeba histolytica. Trop Med Parasitol. 1993 Jun;44(2):116–118. [PubMed] [Google Scholar]
  9. Burch D. J., Li E., Reed S., Jackson T. F., Stanley S. L., Jr Isolation of a strain-specific Entamoeba histolytica cDNA clone. J Clin Microbiol. 1991 Apr;29(4):696–701. doi: 10.1128/jcm.29.4.696-701.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Caballero-Salcedo A., Viveros-Rogel M., Salvatierra B., Tapia-Conyer R., Sepulveda-Amor J., Gutierrez G., Ortiz-Ortiz L. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg. 1994 Apr;50(4):412–419. doi: 10.4269/ajtmh.1994.50.412. [DOI] [PubMed] [Google Scholar]
  11. Carrero J. C., Díaz M. Y., Viveros M., Espinoza B., Acosta E., Ortiz-Ortiz L. Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells. Infect Immun. 1994 Feb;62(2):764–767. doi: 10.1128/iai.62.2.764-767.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chadee K., Meerovitch E. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am J Pathol. 1984 Oct;117(1):71–80. [PMC free article] [PubMed] [Google Scholar]
  13. Cieslak P. R., Zhang T., Stanley S. L., Jr Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain. Vaccine. 1993;11(7):773–776. doi: 10.1016/0264-410x(93)90264-x. [DOI] [PubMed] [Google Scholar]
  14. Clark C. G., Diamond L. S. Entamoeba histolytica: a method for isolate identification. Exp Parasitol. 1993 Dec;77(4):450–455. doi: 10.1006/expr.1993.1105. [DOI] [PubMed] [Google Scholar]
  15. Clark C. G., Diamond L. S. Ribosomal RNA genes of 'pathogenic' and 'nonpathogenic' Entamoeba histolytica are distinct. Mol Biochem Parasitol. 1991 Dec;49(2):297–302. doi: 10.1016/0166-6851(91)90073-f. [DOI] [PubMed] [Google Scholar]
  16. Cuatrecasas P. Gangliosides and membrane receptors for cholera toxin. Biochemistry. 1973 Aug 28;12(18):3558–3566. doi: 10.1021/bi00742a032. [DOI] [PubMed] [Google Scholar]
  17. Curtiss R., 3rd, Kelly S. M., Gulig P. A., Nakayama K. Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol. 1989;146:35–49. doi: 10.1007/978-3-642-74529-4_4. [DOI] [PubMed] [Google Scholar]
  18. Curtiss R., 3rd, Kelly S. M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun. 1987 Dec;55(12):3035–3043. doi: 10.1128/iai.55.12.3035-3043.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Czerkinsky C., Russell M. W., Lycke N., Lindblad M., Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun. 1989 Apr;57(4):1072–1077. doi: 10.1128/iai.57.4.1072-1077.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Czerkinsky C., Svennerholm A. M., Holmgren J. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin Infect Dis. 1993 Mar;16 (Suppl 2):S106–S116. doi: 10.1093/clinids/16.supplement_2.s106. [DOI] [PubMed] [Google Scholar]
  21. Dertzbaugh M. T., Elson C. O. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect Immun. 1993 Jan;61(1):48–55. doi: 10.1128/iai.61.1.48-55.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dertzbaugh M. T., Macrina F. L. Plasmid vectors for constructing translational fusions to the B subunit of cholera toxin. Gene. 1989 Oct 30;82(2):335–342. doi: 10.1016/0378-1119(89)90060-7. [DOI] [PubMed] [Google Scholar]
  23. Dertzbaugh M. T., Peterson D. L., Macrina F. L. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect Immun. 1990 Jan;58(1):70–79. doi: 10.1128/iai.58.1.70-79.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Elson C. O., Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol. 1984 Dec;133(6):2892–2897. [PubMed] [Google Scholar]
  25. Elson C. O., Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol. 1984 Jun;132(6):2736–2741. [PubMed] [Google Scholar]
  26. Flores B. M., Batzer M. A., Stein M. A., Petersen C., Diedrich D. L., Torian B. E. Structural analysis and demonstration of the 29 kDa antigen of pathogenic Entamoeba histolytica as the major accessible free thiol-containing surface protein. Mol Microbiol. 1993 Mar;7(5):755–763. doi: 10.1111/j.1365-2958.1993.tb01166.x. [DOI] [PubMed] [Google Scholar]
  27. Flores B. M., Reed S. L., Ravdin J. I., Torian B. E. Serologic reactivity to purified recombinant and native 29-kilodalton peripheral membrane protein of pathogenic Entamoeba histolytica. J Clin Microbiol. 1993 Jun;31(6):1403–1407. doi: 10.1128/jcm.31.6.1403-1407.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Flores B. M., Stanley S. L., Jr, Yong T. S., Ali M., Yang W., Diedrich D. L., Torian B. E. Surface localization, regulation, and biologic properties of the 96-kDa alcohol/aldehyde dehydrogenase (EhADH2) of pathogenic Entamoeba histolytica. J Infect Dis. 1996 Jan;173(1):226–231. doi: 10.1093/infdis/173.1.226. [DOI] [PubMed] [Google Scholar]
  29. Ghadirian E., Meerovitch E., Hartmann D. P. Protection against amebic liver abscess in hamsters by means of immunization with amebic antigen and some of its fractions. Am J Trop Med Hyg. 1980 Sep;29(5):779–784. doi: 10.4269/ajtmh.1980.29.779. [DOI] [PubMed] [Google Scholar]
  30. Ghadirian E., Meerovitch E. Vaccination against hepatic amebiasis in hamsters. J Parasitol. 1978 Aug;64(4):742–743. [PubMed] [Google Scholar]
  31. González R. A., Sánchez J., Holmgren J., López S., Arias C. F. Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit. Gene. 1993 Nov 15;133(2):227–232. doi: 10.1016/0378-1119(93)90643-h. [DOI] [PubMed] [Google Scholar]
  32. Jain P., Sawhney S., Vinayak V. K. Experimental amoebic infection in guinea-pigs immunized with low grade amoebic infection. Trans R Soc Trop Med Hyg. 1980;74(3):347–350. doi: 10.1016/0035-9203(80)90097-8. [DOI] [PubMed] [Google Scholar]
  33. Jiménez Cardoso J. M., Jiménez E., de Jesús Bernal M., Kumate J. Inducción de inmunidad protectora antiamibiana en hamsters con antígenos heterólogos. Rev Invest Clin. 1989 Apr-Jun;41(2):133–138. [PubMed] [Google Scholar]
  34. Jobling M. G., Holmes R. K. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras. Infect Immun. 1992 Nov;60(11):4915–4924. doi: 10.1128/iai.60.11.4915-4924.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kanani S. R., Knight R. Relapsing amoebic colitis of 12 year's standing exacerbated by corticosteroids. Br Med J. 1969 Jun 7;2(5657):613–614. doi: 10.1136/bmj.2.5657.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Katzenstein D., Rickerson V., Braude A. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine (Baltimore) 1982 Jul;61(4):237–246. doi: 10.1097/00005792-198207000-00003. [DOI] [PubMed] [Google Scholar]
  37. Keene W. E., Hidalgo M. E., Orozco E., McKerrow J. H. Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Exp Parasitol. 1990 Aug;71(2):199–206. doi: 10.1016/0014-4894(90)90022-5. [DOI] [PubMed] [Google Scholar]
  38. Kelsall B. L., Ravdin J. I. Degradation of human IgA by Entamoeba histolytica. J Infect Dis. 1993 Nov;168(5):1319–1322. doi: 10.1093/infdis/168.5.1319. [DOI] [PubMed] [Google Scholar]
  39. Kelsall B. L., Ravdin J. I. Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity. Infect Immun. 1995 Feb;63(2):686–689. doi: 10.1128/iai.63.2.686-689.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Krupp I. M. Antibody response in intestinal and extraintestinal amebiasis. Am J Trop Med Hyg. 1970 Jan;19(1):57–62. doi: 10.4269/ajtmh.1970.19.57. [DOI] [PubMed] [Google Scholar]
  41. Krupp I. M. Protective immunity to amebic infection demonstrated in guinea pigs. Am J Trop Med Hyg. 1974 May;23(3):355–360. doi: 10.4269/ajtmh.1974.23.355. [DOI] [PubMed] [Google Scholar]
  42. Köhler S., Tannich E. A family of transcripts (K2) of Entamoeba histolytica contains polymorphic repetitive regions with highly conserved elements. Mol Biochem Parasitol. 1993 May;59(1):49–58. doi: 10.1016/0166-6851(93)90006-j. [DOI] [PubMed] [Google Scholar]
  43. Lee A., Chen M. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infect Immun. 1994 Aug;62(8):3594–3597. doi: 10.1128/iai.62.8.3594-3597.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Leippe M., Andrä J., Müller-Eberhard H. J. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2602–2606. doi: 10.1073/pnas.91.7.2602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Leippe M., Müller-Eberhard H. J. The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis. Toxicology. 1994 Feb 28;87(1-3):5–18. doi: 10.1016/0300-483x(94)90151-1. [DOI] [PubMed] [Google Scholar]
  46. Li E., Becker A., Stanley S. L., Jr Chinese hamster ovary cells deficient in N-acetylglucosaminyltransferase I activity are resistant to Entamoeba histolytica-mediated cytotoxicity. Infect Immun. 1989 Jan;57(1):8–12. doi: 10.1128/iai.57.1.8-12.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Li E., Becker A., Stanley S. L., Jr Use of Chinese hamster ovary cells with altered glycosylation patterns to define the carbohydrate specificity of Entamoeba histolytica adhesion. J Exp Med. 1988 May 1;167(5):1725–1730. doi: 10.1084/jem.167.5.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Li E., Kunz-Jenkins C., Stanley S. L., Jr Isolation and characterization of genomic clones encoding a serine-rich Entamoeba histolytica protein. Mol Biochem Parasitol. 1992 Feb;50(2):355–357. doi: 10.1016/0166-6851(92)90234-b. [DOI] [PubMed] [Google Scholar]
  49. Li E., Stanley S. L., Jr Protozoa. Amebiasis. Gastroenterol Clin North Am. 1996 Sep;25(3):471–492. doi: 10.1016/s0889-8553(05)70259-4. [DOI] [PubMed] [Google Scholar]
  50. Liang X. P., Lamm M. E., Nedrud J. G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J Immunol. 1988 Sep 1;141(5):1495–1501. [PubMed] [Google Scholar]
  51. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 1986 Oct;59(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  52. Lycke N., Tsuji T., Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol. 1992 Sep;22(9):2277–2281. doi: 10.1002/eji.1830220915. [DOI] [PubMed] [Google Scholar]
  53. Mann B. J., Torian B. E., Vedvick T. S., Petri W. A., Jr Sequence of a cysteine-rich galactose-specific lectin of Entamoeba histolytica. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3248–3252. doi: 10.1073/pnas.88.8.3248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Martínez-Reyes R., González-Pacheco M., Gómez-Reyes I., de la Torre M., Sepúlveda B. Inducción de inmunidad antiamibiásica en primates subhumanos con antígeno lisosomal de Entamoeba histolytica. VI. Inoculación intrahepática de E. histolytica virulenta en monos. Arch Invest Med (Mex) 1980;11(1 Suppl):267–273. [PubMed] [Google Scholar]
  55. McAllister T. A. Diagnosis of Amoebic Colitis on Routine Biopsies from Rectum and Sigmoid Colon. Br Med J. 1962 Feb 10;1(5275):362–366.1. doi: 10.1136/bmj.1.5275.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. McCoy J. J., Mann B. J., Petri W. A., Jr Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun. 1994 Aug;62(8):3045–3050. doi: 10.1128/iai.62.8.3045-3050.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. McCoy J. J., Mann B. J., Vedvick T. S., Pak Y., Heimark D. B., Petri W. A., Jr Structural analysis of the light subunit of the Entamoeba histolytica galactose-specific adherence lectin. J Biol Chem. 1993 Nov 15;268(32):24223–24231. [PubMed] [Google Scholar]
  58. McCoy J. J., Mann B. J., Vedvick T. S., Petri W. A., Jr Sequence analysis of genes encoding the light subunit of the Entamoeba histolytica galactose-specific adhesin. Mol Biochem Parasitol. 1993 Oct;61(2):325–328. doi: 10.1016/0166-6851(93)90079-d. [DOI] [PubMed] [Google Scholar]
  59. McKenzie S. J., Halsey J. F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol. 1984 Oct;133(4):1818–1824. [PubMed] [Google Scholar]
  60. Myung K., Burch D., Jackson T. F., Stanley S. L., Jr Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica antigen-based ELISA. Arch Med Res. 1992;23(2):285–288. [PubMed] [Google Scholar]
  61. Nardelli-Haefliger D., Kraehenbuhl J. P., Curtiss R., 3rd, Schodel F., Potts A., Kelly S., De Grandi P. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun. 1996 Dec;64(12):5219–5224. doi: 10.1128/iai.64.12.5219-5224.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Osorio L. M., Picó T., Luaces A. Circulating antibodies to histolysain, the major cysteine proteinase of Entamoeba histolytica, in amoebic liver abscess patients. Parasitology. 1992 Oct;105(Pt 2):207–210. doi: 10.1017/s0031182000074126. [DOI] [PubMed] [Google Scholar]
  63. Petri W. A., Jr, Chapman M. D., Snodgrass T., Mann B. J., Broman J., Ravdin J. I. Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem. 1989 Feb 15;264(5):3007–3012. [PubMed] [Google Scholar]
  64. Petri W. A., Jr, Ravdin J. I. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun. 1991 Jan;59(1):97–101. doi: 10.1128/iai.59.1.97-101.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Petri W. A., Jr, Snodgrass T. L., Jackson T. F., Gathiram V., Simjee A. E., Chadee K., Chapman M. D. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J Immunol. 1990 Jun 15;144(12):4803–4809. [PubMed] [Google Scholar]
  67. Phillips R. S. Vaccination against malaria. Immunobiology. 1992 Feb;184(2-3):240–262. doi: 10.1016/S0171-2985(11)80478-X. [DOI] [PubMed] [Google Scholar]
  68. Purdy J. E., Mann B. J., Shugart E. C., Petri W. A., Jr Analysis of the gene family encoding the Entamoeba histolytica galactose-specific adhesin 170-kDa subunit. Mol Biochem Parasitol. 1993 Nov;62(1):53–59. doi: 10.1016/0166-6851(93)90177-y. [DOI] [PubMed] [Google Scholar]
  69. Ravdin J. I., Guerrant R. L. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest. 1981 Nov;68(5):1305–1313. doi: 10.1172/JCI110377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Ravdin J. I., Jackson T. F., Petri W. A., Jr, Murphy C. F., Ungar B. L., Gathiram V., Skilogiannis J., Simjee A. E. Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica. J Infect Dis. 1990 Sep;162(3):768–772. doi: 10.1093/infdis/162.3.768. [DOI] [PubMed] [Google Scholar]
  71. Ravdin J. I., Petri W. A., Murphy C. F., Smith R. D. Production of mouse monoclonal antibodies which inhibit in vitro adherence of Entamoeba histolytica trophozoites. Infect Immun. 1986 Jul;53(1):1–5. doi: 10.1128/iai.53.1.1-5.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ravdin J. I., Stanley P., Murphy C. F., Petri W. A., Jr Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin. Infect Immun. 1989 Jul;57(7):2179–2186. doi: 10.1128/iai.57.7.2179-2186.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Reed S. L., Flores B. M., Batzer M. A., Stein M. A., Stroeher V. L., Carlton J. E., Diedrich D. L., Torian B. E. Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates. Infect Immun. 1992 Feb;60(2):542–549. doi: 10.1128/iai.60.2.542-549.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Reed S., Bouvier J., Pollack A. S., Engel J. C., Brown M., Hirata K., Que X., Eakin A., Hagblom P., Gillin F. Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene. J Clin Invest. 1993 Apr;91(4):1532–1540. doi: 10.1172/JCI116359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Robbins J. B., Schneerson R., Szu S. C. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis. 1995 Jun;171(6):1387–1398. doi: 10.1093/infdis/171.6.1387. [DOI] [PubMed] [Google Scholar]
  76. Russell M. W., Wu H. Y. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun. 1991 Nov;59(11):4061–4070. doi: 10.1128/iai.59.11.4061-4070.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Ryan E. T., Butterton J. R., Zhang T., Baker M. A., Stanley S. L., Jr, Calderwood S. B. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect Immun. 1997 Aug;65(8):3118–3125. doi: 10.1128/iai.65.8.3118-3125.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. SWARTZWELDER J. C., AVANT W. H. Immunity to amebic infection in dogs. Am J Trop Med Hyg. 1952 Jul;1(4):567–575. doi: 10.4269/ajtmh.1952.1.567. [DOI] [PubMed] [Google Scholar]
  79. Salata R. A., Cox J. G., Ravdin J. I. The interaction of human T-lymphocytes and Entamoeba histolytica: killing of virulent amoebae by lectin-dependent lymphocytes. Parasite Immunol. 1987 Mar;9(2):249–261. doi: 10.1111/j.1365-3024.1987.tb00504.x. [DOI] [PubMed] [Google Scholar]
  80. Salata R. A., Martinez-Palomo A., Murray H. W., Conales L., Trevino N., Segovia E., Murphy C. F., Ravdin J. I. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol. 1986 Apr 1;136(7):2633–2639. [PubMed] [Google Scholar]
  81. Salata R. A., Pearson R. D., Ravdin J. I. Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest. 1985 Aug;76(2):491–499. doi: 10.1172/JCI111998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sanchez J. L., Trofa A. F., Taylor D. N., Kuschner R. A., DeFraites R. F., Craig S. C., Rao M. R., Clemens J. D., Svennerholm A. M., Sadoff J. C. Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers. J Infect Dis. 1993 Jun;167(6):1446–1449. doi: 10.1093/infdis/167.6.1446. [DOI] [PubMed] [Google Scholar]
  83. Sargeaunt P. G., Williams J. E. Electrophoretic isoenzyme patterns of Entamoeba histolytica and Entamoeba coli. Trans R Soc Trop Med Hyg. 1978;72(2):164–166. doi: 10.1016/0035-9203(78)90053-6. [DOI] [PubMed] [Google Scholar]
  84. Sargeaunt P. G., Williams J. E. Electrophoretic isoenzyme patterns of the pathogenic and non-pathogenic intestinal amoebae of man. Trans R Soc Trop Med Hyg. 1979;73(2):225–227. doi: 10.1016/0035-9203(79)90219-0. [DOI] [PubMed] [Google Scholar]
  85. Sargeaunt P. G., Williams J. E., Grene J. D. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg. 1978;72(5):519–521. doi: 10.1016/0035-9203(78)90174-8. [DOI] [PubMed] [Google Scholar]
  86. Schain D. C., Salata R. A., Ravdin J. I. Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun. 1992 May;60(5):2143–2146. doi: 10.1128/iai.60.5.2143-2146.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Schödel F., Kelly S. M., Peterson D. L., Milich D. R., Curtiss R., 3rd Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun. 1994 May;62(5):1669–1676. doi: 10.1128/iai.62.5.1669-1676.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Sepúlveda B. Inducción de inmunidad antiamibiásica en primates subhumanos con antígeno lisosomal de Entamoeba histolytica. VII. Comentarios y conclusiones. Arch Invest Med (Mex) 1980;11(1 Suppl):275–276. [PubMed] [Google Scholar]
  89. Sepúlveda B., Tanimoto-Weki M., Calderón P., de la Torre M. Neutralización de la virulencia en cultivos de E. histolytica con suero inmune. Arch Invest Med (Mex) 1974;5(Suppl 2):447–450. [PubMed] [Google Scholar]
  90. Seydel K. B., Braun K. L., Zhang T., Jackson T. F., Stanley S. L., Jr Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies. Am J Trop Med Hyg. 1996 Sep;55(3):330–332. doi: 10.4269/ajtmh.1996.55.330. [DOI] [PubMed] [Google Scholar]
  91. Soong C. J., Kain K. C., Abd-Alla M., Jackson T. F., Ravdin J. I. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis. 1995 Mar;171(3):645–651. doi: 10.1093/infdis/171.3.645. [DOI] [PubMed] [Google Scholar]
  92. Soong C. J., Torian B. E., Abd-Alla M. D., Jackson T. F., Gatharim V., Ravdin J. I. Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect Immun. 1995 Feb;63(2):472–477. doi: 10.1128/iai.63.2.472-477.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Stanley S. L., Jr, Becker A., Kunz-Jenkins C., Foster L., Li E. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4976–4980. doi: 10.1073/pnas.87.13.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Stanley S. L., Jr, Blanchard J. L., Johnson N., Foster L., Kunz-Jenkins C., Zhang T., Tian K., Cogswell F. B. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey. Vaccine. 1995 Jul;13(10):947–951. doi: 10.1016/0264-410x(95)00001-h. [DOI] [PubMed] [Google Scholar]
  95. Stanley S. L., Jr, Huizenga H., Li E. Isolation and partial characterization of a surface glycoconjugate of Entamoeba histolytica. Mol Biochem Parasitol. 1992 Jan;50(1):127–138. doi: 10.1016/0166-6851(92)90250-n. [DOI] [PubMed] [Google Scholar]
  96. Stanley S. L., Jr, Jackson T. F., Reed S. L., Calderon J., Kunz-Jenkins C., Gathiram V., Li E. Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica protein. JAMA. 1991 Oct 9;266(14):1984–1986. [PubMed] [Google Scholar]
  97. Stanley S. L., Jr, Tian K., Koester J. P., Li E. The serine-rich Entamoeba histolytica protein is a phosphorylated membrane protein containing O-linked terminal N-acetylglucosamine residues. J Biol Chem. 1995 Feb 24;270(8):4121–4126. doi: 10.1074/jbc.270.8.4121. [DOI] [PubMed] [Google Scholar]
  98. Stanley S. L., Jr, Zhang T., Rubin D., Li E. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect Immun. 1995 Apr;63(4):1587–1590. doi: 10.1128/iai.63.4.1587-1590.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Tachibana H., Kobayashi S., Kato Y., Nagakura K., Kaneda Y., Takeuchi T. Identification of a pathogenic isolate-specific 30,000-Mr antigen of Entamoeba histolytica by using a monoclonal antibody. Infect Immun. 1990 Apr;58(4):955–960. doi: 10.1128/iai.58.4.955-960.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Tacket C. O., Hone D. M., Curtiss R., 3rd, Kelly S. M., Losonsky G., Guers L., Harris A. M., Edelman R., Levine M. M. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun. 1992 Feb;60(2):536–541. doi: 10.1128/iai.60.2.536-541.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Tamura S., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 1988 Oct;6(5):409–413. doi: 10.1016/0264-410x(88)90140-5. [DOI] [PubMed] [Google Scholar]
  102. Tannich E., Bruchhaus I., Walter R. D., Horstmann R. D. Pathogenic and nonpathogenic Entamoeba histolytica: identification and molecular cloning of an iron-containing superoxide dismutase. Mol Biochem Parasitol. 1991 Nov;49(1):61–71. doi: 10.1016/0166-6851(91)90130-x. [DOI] [PubMed] [Google Scholar]
  103. Tannich E., Burchard G. D. Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro. J Clin Microbiol. 1991 Feb;29(2):250–255. doi: 10.1128/jcm.29.2.250-255.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Tannich E., Ebert F., Horstmann R. D. Molecular cloning of cDNA and genomic sequences coding for the 35-kilodalton subunit of the galactose-inhibitable lectin of pathogenic Entamoeba histolytica. Mol Biochem Parasitol. 1992 Oct;55(1-2):225–227. doi: 10.1016/0166-6851(92)90144-9. [DOI] [PubMed] [Google Scholar]
  105. Tannich E., Ebert F., Horstmann R. D. Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1849–1853. doi: 10.1073/pnas.88.5.1849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Tannich E., Horstmann R. D., Knobloch J., Arnold H. H. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5118–5122. doi: 10.1073/pnas.86.13.5118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Tannich E., Scholze H., Nickel R., Horstmann R. D. Homologous cysteine proteinases of pathogenic and nonpathogenic Entamoeba histolytica. Differences in structure and expression. J Biol Chem. 1991 Mar 15;266(8):4798–4803. [PubMed] [Google Scholar]
  108. Torian B. E., Flores B. M., Stroeher V. L., Hagen F. S., Stamm W. E. cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6358–6362. doi: 10.1073/pnas.87.16.6358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Velazquez C., Valette I., Cruz M., Labra M. L., Montes J., Stanley S. L., Jr, Calderon J. Identification of immunogenic epitopes of the 170-kDa subunit adhesin of Entamoeba histolytica in patients with invasive amebiasis. J Eukaryot Microbiol. 1995 Sep-Oct;42(5):636–641. doi: 10.1111/j.1550-7408.1995.tb05920.x. [DOI] [PubMed] [Google Scholar]
  110. Vinayak V. K., Sawhney S., Jain P., Chakravarti R. N. Protective effects of crude and chromatographic fractions of axenic Entamoeba histolytica in guinea-pigs. Trans R Soc Trop Med Hyg. 1980;74(4):483–487. doi: 10.1016/0035-9203(80)90063-2. [DOI] [PubMed] [Google Scholar]
  111. Vázquez-Saavedra J. A., Tanimoto-Weki M., Olivera-López J. I., Caracheo-Reyes F., Cortés-Arcos A. Inmunidad consecutiva a infección amibiana curada en el hamster. Arch Invest Med (Mex) 1973;(Suppl):155–158. [PubMed] [Google Scholar]
  112. Walsh J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986 Mar-Apr;8(2):228–238. doi: 10.1093/clinids/8.2.228. [DOI] [PubMed] [Google Scholar]
  113. Yang W., Li E., Kairong T., Stanley S. L., Jr Entamoeba histolytica has an alcohol dehydrogenase homologous to the multifunctional adhE gene product of Escherichia coli. Mol Biochem Parasitol. 1994 Apr;64(2):253–260. doi: 10.1016/0166-6851(93)00020-a. [DOI] [PubMed] [Google Scholar]
  114. Yong T. S., Li E., Clark D., Stanley S. L., Jr Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new antiamebic drugs. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6464–6469. doi: 10.1073/pnas.93.13.6464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Zhang T., Cieslak P. R., Foster L., Kunz-Jenkins C., Stanley S. L., Jr Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol. 1994 May;16(5):225–230. doi: 10.1111/j.1365-3024.1994.tb00344.x. [DOI] [PubMed] [Google Scholar]
  116. Zhang T., Cieslak P. R., Stanley S. L., Jr Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect Immun. 1994 Apr;62(4):1166–1170. doi: 10.1128/iai.62.4.1166-1170.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Zhang T., Li E., Stanley S. L., Jr Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect Immun. 1995 Apr;63(4):1349–1355. doi: 10.1128/iai.63.4.1349-1355.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Zhang T., Stanley S. L., Jr Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect Immun. 1996 May;64(5):1526–1531. doi: 10.1128/iai.64.5.1526-1531.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Zhang T., Stanley S. L., Jr Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect Immun. 1994 Jun;62(6):2605–2608. doi: 10.1128/iai.62.6.2605-2608.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Zhang Y., Li E., Jackson T. F., Zhang T., Gathiram V., Stanley S. L., Jr Use of a recombinant 170-kilodalton surface antigen of Entamoeba histolytica for serodiagnosis of amebiasis and identification of immunodominant domains of the native molecule. J Clin Microbiol. 1992 Nov;30(11):2788–2792. doi: 10.1128/jcm.30.11.2788-2792.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES